Tomohide Tatsumi

9.9k citations

185 papers · 6.9k indexed · h-index 46

Immunology top 0.5%
Molecular Biology top 5%
Epidemiology top 1%
Hepatology top 0.5%
Oncology top 2%

Co-authors: Tetsuo Takehara Norio Hayashi Tatsuya Kanto Takuya Miyagi Hayato Hikita Ryotaro Sakamori Takahiro Kodama Masahisa Jinushi
Topics: Hepatitis C virus research (44 papers)Liver Disease Diagnosis and Treatment (42 papers)Hepatitis B Virus Studies (36 papers)
Cited by: Hepatology Immunology Oncology
Journals: Journal of Biological Chemistry Journal of Clinical Investigation The Journal of Experimental Medicine
Partner nations: Japan United States Slovakia

In The Last Decade

Tomohide Tatsumi

177 papers receiving 6.8k citations

Peers

Countries citing papers authored by Tomohide Tatsumi

Since Specialization

Citations

This map shows the geographic impact of Tomohide Tatsumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohide Tatsumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohide Tatsumi more than expected).

Fields of papers citing papers by Tomohide Tatsumi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohide Tatsumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohide Tatsumi. The network helps show where Tomohide Tatsumi may publish in the future.

Co-authorship network of co-authors of Tomohide Tatsumi

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohide Tatsumi. A scholar is included among the top collaborators of Tomohide Tatsumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohide Tatsumi. Tomohide Tatsumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic impact of worsening of esophageal varices after balloon‐occluded retrograde transvenous obliteration 2022 ·Journal of Gastroenterology and Hepatology ·(unknown),Ryotaro Sakamori,(unknown),Yuki Tahata,Yasutoshi Nozaki,Kengo Matsumoto,(unknown),Kazuto Fukuda,Yuichi Yoshida,Satoshi Tanaka,Toshifumi Ito,Yoshinori Doi,Sadaharu Iio,Mitsuru Sakakibara,Fumihiko Nakanishi,Takahiro Kodama,Hayato Hikita,Tomohide Tatsumi,Tetsuo Takehara	0
2	Pentraxin 3 is an adipose tissue‐related serum marker for pancreatic cancer cachexia predicting subsequent muscle mass and visceral fat loss 2022 ·Cancer Science ·Katsuhiko Sato,Hayato Hikita,Minoru Shigekawa,Seiya Kato,Yōichi Sasaki,(unknown),Makoto Fukuoka,(unknown),(unknown),Kenji Fukumoto,(unknown),Yuta Myojin,Sadatsugu Sakane,Kazuhiro Murai,Teppei Yoshioka,(unknown),Takahiro Kodama,Ryotaro Sakamori,Tomohide Tatsumi,Tetsuo Takehara	7
3	Clinical course of hepatitis C virus‐positive patients with decompensated liver cirrhosis in the era of direct‐acting antiviral treatment 2021 ·Hepatology Research ·Kazuki Maesaka,Ryotaro Sakamori,Ryoko Yamada,Yuki Tahata,Masahide Oshita,Hideki Hagiwara,Mitsuru Sakakibara,Shinji Tamura,Naoki Hiramatsu,Masami Inada,Sadaharu Iio,Toshifumi Ito,Takayuki Yakushijin,Yoshinori Doi,Takahiro Kodama,Hayato Hikita,Tomohide Tatsumi,Tetsuo Takehara	3
4	Capsid Allosteric Modulators Enhance the Innate Immune Response in Hepatitis B Virus–Infected Hepatocytes During Interferon Administration 2021 ·Hepatology Communications ·(unknown),Hayato Hikita,Kazuhiro Murai,Tasuku Nakabori,(unknown),Makoto Fukuoka,Takuo Yamai,Yuichiro Higuchi,Kei Miyakawa,Hiroshi Suemizu,Akihide Ryo,Ryoko Yamada,Takahiro Kodama,Ryotaro Sakamori,Tomohide Tatsumi,Tetsuo Takehara	4
5	Activation of p53 After Irradiation Impairs the Regenerative Capacity of the Mouse Liver 2021 ·Hepatology Communications ·(unknown),Hayato Hikita,Yoshinobu Saito,(unknown),Kenji Fukumoto,Naoki Mizutani,Yuta Myojin,(unknown),Katsuhiko Sato,Sadatsugu Sakane,Yuki Makino,Takahiro Kodama,Ryotaro Sakamori,Tomohide Tatsumi,Tetsuo Takehara	3
6	Transcriptomics Identify Thrombospondin‐2 as a Biomarker for NASH and Advanced Liver Fibrosis 2021 ·Hepatology ·(unknown),Takahiro Kodama,(unknown),Sadatsugu Sakane,Olivier Govaere,Simon Cockell,Daisuke Motooka,Naruyasu Kakita,Yukinori Yamada,Yasuteru Kondo,Yuki Tahata,Ryoko Yamada,Hayato Hikita,Ryotaro Sakamori,Yoshihiro Kamada,Ann K. Daly,Quentin M. Anstee,Tomohide Tatsumi,Eiichi Morii,Tetsuo Takehara	99
7	Therapeutic efficacy of lenvatinib in hepatocellular carcinoma patients with portal hypertension 2020 ·Hepatology Research ·Kazuki Maesaka,Ryotaro Sakamori,Ryoko Yamada,(unknown),Yuki Tahata,Masahide Oshita,Kazuyoshi Ohkawa,Eiji Mita,Hideki Hagiwara,Shinji Tamura,Toshifumi Ito,Takayuki Yakushijin,Sadaharu Iio,Takahiro Kodama,Hayato Hikita,Tomohide Tatsumi,Tetsuo Takehara	2
8	Endoscopic biliary stenting as the risk factor for cholangitis after endoscopic ultrasound in patients with biliary strictures 2020 ·Journal of Gastroenterology and Hepatology ·Kenji Ikezawa,Minoru Shigekawa,Takuo Yamai,(unknown),(unknown),Teppei Yoshioka,Ryotaro Sakamori,Tomohide Tatsumi,Tetsuo Takehara	5
9	Hepatitis C virus infection suppresses hepatitis B virus replication via the RIG-I-like helicase pathway 2020 ·Scientific Reports ·Kazuhiro Murai,Hayato Hikita,Yugo Kai,Yasuteru Kondo,Makoto Fukuoka,(unknown),Akira Doi,Takuo Yamai,Tasuku Nakabori,Ryo Fukuda,Takeshi Takahashi,Kei Miyakawa,Hiroshi Suemizu,Akihide Ryo,Ryoko Yamada,Takahiro Kodama,Ryotaro Sakamori,Tomohide Tatsumi,Tetsuo Takehara	17
10	ST6GAL1 Is a Novel Serum Biomarker for Lenvatinib-Susceptible FGF19-Driven Hepatocellular Carcinoma 2020 ·Clinical Cancer Research ·Yuta Myojin,Takahiro Kodama,Kazuki Maesaka,Daisuke Motooka,Yu Sato,Satoshi Tanaka,Yuichi Abe,Kazuyoshi Ohkawa,Eiji Mita,Yoshito Hayashi,Hayato Hikita,Ryotaro Sakamori,Tomohide Tatsumi,Ayumu Taguchi,Hidetoshi Eguchi,Tetsuo Takehara	57
11	Pre-existing minor variants with NS5A L31M/V-Y93H double substitution are closely linked to virologic failure with asunaprevir plus daclatasvir treatment for genotype 1b hepatitis C virus infection 2020 ·PLoS ONE ·Naoki Morishita,Ryotaro Sakamori,Tomomi Yamada,Yugo Kai,Yuki Tahata,(unknown),Ryoko Yamada,Takahiro Kodama,Hayato Hikita,Yoshinori Doi,Shinji Tamura,Hideki Hagiwara,Yasuharu Imai,Sadaharu Iio,Tomohide Tatsumi,Tetsuo Takehara	0
12	Hypovascular hepatic nodules as a predictive factor for transcatheter arterial chemoembolization refractoriness in hepatocellular carcinoma 2019 ·Hepatology Research ·Kazuki Maesaka,Ryotaro Sakamori,Ryoko Yamada,Yuki Tahata,(unknown),Minoru Shigekawa,Takahiro Kodama,Hayato Hikita,Tomohide Tatsumi,Tetsuo Takehara	12
13	CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma 2019 ·Cancers ·(unknown),Takahiro Kodama,Yuta Myojin,Ryoko Yamada,Minoru Shigekawa,Hayato Hikita,Ryotaro Sakamori,Tomohide Tatsumi,Tetsuo Takehara	26
14	Forkhead Box M1 Transcription Factor Drives Liver Inflammation Linking to Hepatocarcinogenesis in Mice 2019 ·Cellular and Molecular Gastroenterology and Hepatology ·(unknown),Yuichi Yoshida,(unknown),(unknown),Kunimaro Furuta,Hayato Hikita,Takahiro Kodama,Ryotaro Sakamori,Shinichi Kiso,Yoshihiro Kamada,I‐Ching Wang,Hidetoshi Eguchi,Eiichi Morii,Yuichiro� Doki,Masaki Mori,Vladimir V. Kalinichenko,Tomohide Tatsumi,Tetsuo Takehara	24
15	Cotreatment with lenvatinib and warfarin potassium caused prothrombin time prolongation 2019 ·Hepatology Research ·Yōichi Sasaki,Ryotaro Sakamori,Ryoko Yamada,Minoru Shigekawa,Yuki Tahata,Yuki Makino,Tasuku Nakabori,Takahiro Kodama,Hayato Hikita,Tomohide Tatsumi,Tetsuo Takehara	4
16	Hepatocellular carcinoma occurrence does not differ between interferon‐based and interferon‐free treatment with liver histological assessment 2019 ·Hepatology Research ·Yuki Tahata,Ryotaro Sakamori,(unknown),Ryoko Yamada,Kazuyoshi Ohkawa,Naoki Hiramatsu,Hideki Hagiwara,Masahide Oshita,Taizo Hijioka,Shinji Tamura,Yasuharu Imai,Takahiro Kodama,Hayato Hikita,Tomohide Tatsumi,Tetsuo Takehara	4
17	CTGF Mediates Tumor–Stroma Interactions between Hepatoma Cells and Hepatic Stellate Cells to Accelerate HCC Progression 2018 ·Cancer Research ·Yuki Makino,Hayato Hikita,Takahiro Kodama,Minoru Shigekawa,Ryoko Yamada,Ryotaro Sakamori,Hidetoshi Eguchi,Eiichi Morii,Hideki Yokoi,Masashi Mukoyama,Hiroshi Suemizu,Tomohide Tatsumi,Tetsuo Takehara	93
18	Increased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and Apoptosis 2017 ·Cellular and Molecular Gastroenterology and Hepatology ·Kenji Ikezawa,Hayato Hikita,Minoru Shigekawa,(unknown),Hidetoshi Eguchi,Ryotaro Sakamori,Tomohide Tatsumi,Tetsuo Takehara	23
19	Activation of the Mitochondrial Apoptotic Pathway Produces Reactive Oxygen Species and Oxidative Damage in Hepatocytes That Contribute to Liver Tumorigenesis 2015 ·Cancer Prevention Research ·Hayato Hikita,Takahiro Kodama,Satoshi Tanaka,Yoshinobu Saito,Yasutoshi Nozaki,Tasuku Nakabori,Satoshi Shimizu,Yoshito Hayashi,Wěi Li,Minoru Shigekawa,Ryotaro Sakamori,Takuya Miyagi,Naoki Hiramatsu,Tomohide Tatsumi,Tetsuo Takehara	20
20	Anticancer Chemotherapy Inhibits MHC Class I–Related Chain A Ectodomain Shedding by Downregulating ADAM10 Expression in Hepatocellular Carcinoma 2009 ·Cancer Research ·Keisuke Kohga,Tetsuo Takehara,Tomohide Tatsumi,Takuya Miyagi,Hisashi Ishida,Kazuyoshi Ohkawa,Tatsuya Kanto,Naoki Hiramatsu,Norio Hayashi	73

About Tomohide Tatsumi

Tomohide Tatsumi is a scholar working on Hepatology, Immunology and Epidemiology, having authored 185 papers that have together received 6.9k indexed citations. Recurring topics across this work include Hepatitis C virus research (44 papers), Liver Disease Diagnosis and Treatment (42 papers) and Hepatitis B Virus Studies (36 papers). The work is most often cited by research in Hepatology (1.6k citations), Immunology (2.9k citations) and Oncology (1.6k citations). Tomohide Tatsumi has collaborated with scholars based in Japan, United States and Slovakia. Frequent co-authors include Tetsuo Takehara, Norio Hayashi, Tatsuya Kanto, Takuya Miyagi, Hayato Hikita, Ryotaro Sakamori, Takahiro Kodama, Masahisa Jinushi, Naoki Hiramatsu and Walter J. Storkus. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact